Although the activity of mFAO has not been studied in cancer cells containing simultaneously mutations in the Krebs cycle, it is worth asking: how can mFAO work with a disrupted Krebs cycle due to mutations in SDH, FH, and/or a-KGDH? The gene discussed is FH; the disease is cancer.